NCT05302180

Brief Summary

The lack of pain specialists limits users' access to non-pharmacological therapeutic pain control strategies. In this context, digital health programs can reduce the inequity of access to interventions, contribute to the self-management of chronic musculoskeletal conditions, reduce the burden on primary care and can help to reorganize the flow of referral of individuals in the health care network. The aim of this study will be to analyze the implementation and health outcomes of three online pain neuroscience education strategies in individuals with chronic musculoskeletal pain. This is a hybrid type III effectiveness-implementation randomized controlled trial. Individuals with ≥18 years old with chronic musculoskeletal pain will be recruited from primary health care in the city of Guarapuava/PR/Brazil and referred to the health care network for conventional physical therapy in addition to the online pain neuroscience education program (EducaDor). The EducaDor program will be delivered in 3 modalities: 1) synchronous online; 2) asynchronous videos; 3) Interactive e-book. The implementation outcomes evaluated will be: acceptability, appropriateness, feasibility, adoption, fidelity, penetration, sustainability and costs; and health outcomes will include: pain, functionality, quality of life, sleep, physical activity, self-efficacy, adverse effects, prognostic and risk groups. The evaluations will be done at baseline, after the end of the interventions and follow-up of 6 months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
249

participants targeted

Target at P75+ for not_applicable chronic-pain

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 31, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

October 27, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2022

Enrollment Period

1.1 years

First QC Date

February 15, 2022

Last Update Submit

December 20, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline pain at 10 week of the intervention

    numerical rating scale (NRS) of 11 points, ranging from 0 (no pain) to 10 points (the worst possible pain) points

    baseline, 10 week

  • Maintenance of pain at 6 months of the intervention

    numerical rating scale (NRS) of 11 points, ranging from 0 (no pain) to 10 points (the worst possible pain) points

    up to 6 months

Secondary Outcomes (12)

  • Change from baseline self-efficacy at 10 week of the intervention

    baseline, 10 week

  • Change from baseline function at 10 week of the intervention

    baseline, 10 week

  • Maintenance of function at 6 months of the intervention

    up to 6 months

  • Change from baseline quality of sleep at 10 week of the intervention

    baseline, 10 week

  • Maintenance of quality of sleep at 6 months of the intervention

    up to 6 months

  • +7 more secondary outcomes

Other Outcomes (11)

  • Assessment of the intervention acceptability by the perspective of public health managers

    through study completion, an average 24 months

  • Assessment of the intervention acceptability by the perspective of participants

    10 week

  • Assessment of the intervention appropriateness by the participants' perspective

    10 week

  • +8 more other outcomes

Study Arms (3)

Synchronous online group

EXPERIMENTAL

The synchronous online pain neuroscience education program (EducaDor program) will be held in groups at until 12 participants, at 10 weekly synchronous meetings on the Whereby® platform.The professional will conduct each synchronous meeting with dialogued exhibition class using multimedia material shared on the computer screen

Other: Pain neuroscience educationOther: Usual care

Asynchronous group

EXPERIMENTAL

Participants allocated in the asynchronous group will receive the interactive e-book at the beginning of the program and ten videos (one per week) with the same topics of synchronous online EducaDor program sent on their smartphone devices and e-mail, in addition to usual care. Before receiving the materials, users will participate in an individual or group synchronous meeting of up to 12 participants on the Whereby® platform to receive a guidance for the use of interactive e-book and access to videos over the 10 weeks. The videos were previously developed and tested in another clinical trial.

Other: Pain neuroscience educationOther: Usual care

E-book group

ACTIVE COMPARATOR

Participants allocated to this group will receive the interactive e-book of EducaDor program in their smartphone devices and e-mail, in addition to usual care. Before receiving the e-book, the users will also participate in an individual or group synchronous meeting of up to 12 participants on the Whereby® platform to receive a guidance for the use of interactive e-book over the 10 weeks.

Other: Pain neuroscience educationOther: Usual care

Interventions

The online pain neuroscience education program will be based on the model proposed by the Pain Research Group, available in http://pesquisaemdor.com.br, which presents the "Path of Recovery". In our program we will hold 10 meetings: (1) conversation with the group, (2) acceptance and pain education, (3) continuation about pain education, (4) sleep hygiene, (5) pharmacological assistance, (6) recognizing stress and negative emotions, (7) increasing positive coping in lifestyle, (8) exercises, (9) communication, and (10) prevention of recurrence. The program will be offered by synchronous meetings; asynchronous (videos) and e-book.

Asynchronous groupE-book groupSynchronous online group

All participants will receive usual care in one of the five physiotherapy clinics accredited to SUS, according to availability of scheduling in the services. The usual care consists of 10 sessions of physical therapy, that is mainly composed by kinesiotherapy and electrothermophototherapy.

Asynchronous groupE-book groupSynchronous online group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals that report musculoskeletal pain in the last 3 months;
  • can read and write in Portuguese language;
  • have smartphone, tablet or computer with internet access.
  • Participants will be included in the study after agreeing and signing the Informed Consent Form (ICF).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Estadual do Centro-Oeste

Guarapuava, Paraná, 85.065-580, Brazil

RECRUITING

Related Publications (1)

  • Baroni MP, Hespanhol L, Miyamoto GC, Daniel CR, Fernandes LG, Dos Reis FJJ, Pate JW, Saragiotto BT. Implementation of an online pain science education for chronic musculoskeletal pain in Brazilian public health system: protocol for a hybrid type III randomised controlled trial with economic evaluation. BMC Musculoskelet Disord. 2023 Apr 10;24(1):277. doi: 10.1186/s12891-023-06360-7.

MeSH Terms

Conditions

Chronic PainMusculoskeletal Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The outcomes' evaluators will be blind about the allocation of participants in the study groups and they will be questioned at the end of the study on which group they believe that each participant was allocated in order to evaluate the success/failure of blinding. Due to the nature of the interventions it will not be possible to blind the participants and researchers responsible for the interventions.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: hybrid type III effectiveness-implementation randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

February 15, 2022

First Posted

March 31, 2022

Study Start

October 27, 2022

Primary Completion

December 1, 2023

Study Completion

March 1, 2025

Last Updated

December 21, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations